×
About 5,294 results

ALLMedicine™ Nasal Polyps Center

Research & Reviews  2,587 results

Predictive Significance of Charcot-Leyden Crystal Protein in Nasal Secretions in Recurr...
https://doi.org/10.1159/000510120
International Archives of Allergy and Immunology; Wu D, Yan B et. al.

Sep 14th, 2020 - The recurrence occurs frequently among patients with chronic rhinosinusitis with nasal polyps (CRSwNP), and predictors that could be conveniently detected during practice in outpatient service are needed. We aimed to illustrate that the concentrat...

Azithromycin for chronic eosinophilic rhinosinusitis with nasal polyp: a placebo-contro...
https://doi.org/10.4193/Rhin20.071
Rhinology de Oliveira IS, Guimaraes AF et. al.

Sep 14th, 2020 - Chronic eosinophilic rhinosinusitis with nasal polyps (CRSwNP eosinophilic) is characterised by the formation of benign and bilateral nasal polyps. We aimed to compare the effectiveness of azithromycin as an immunomodulator with the use of a place...

Denatonium benzoate bitter taste perception in chronic rhinosinusitis subgroups.
https://doi.org/10.1002/alr.22687
International Forum of Allergy & Rhinology References; Civantos AM, Maina IW et. al.

Sep 4th, 2020 - Chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) and CRS without nasal polyps (CRSsNP), and aspirin-exacerbated respiratory disease (AERD) have varying levels of inflammation and disease severity. Solitary chemosensory cells (SCCs) are enri...

Increased lipopolysaccharide content is positively correlated with glucocorticoid recep...
https://doi.org/10.1002/iid3.346
Immunity, Inflammation and Disease REFERENCES; Wang SB, Chen SM et. al.

Sep 1st, 2020 - Chronic rhinosinusitis with nasal polyps (CRSwNP) is a common and frequently occurring disease of the upper respiratory tract. The nasal instillation of the Gram-negative (G- ) bacterial product lipopolysaccharide (LPS) can induce not only acute s...

Systematic literature review of humanistic and economic burdens of chronic rhinosinusit...
https://doi.org/10.1080/03007995.2020.1815683
Current Medical Research and Opinion; Chen S, Zhou A et. al.

Aug 26th, 2020 - Objectives: We conducted a systematic literature review (SLR) of randomized controlled trials and real-world evidence (RWE) studies to determine the humanistic (e.g., health-related/disease-specific quality of life [QOL]) and economic (e.g., direc...

see more →

Guidelines  1 results

Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI posit...
https://doi.org/10.1111/all.13599
Allergy Kowalski ML, Agache I et. al.

Sep 14th, 2018 - NSAID-exacerbated respiratory disease (N-ERD) is a chronic eosinophilic, inflammatory disorder of the respiratory tract occurring in patients with asthma and/or chronic rhinosinusitis with nasal polyps (CRSwNP), symptoms of which are exacerbated b...

see more →

Drugs  17 results see all →

Clinicaltrials.gov  2,645 results

Predictive Significance of Charcot-Leyden Crystal Protein in Nasal Secretions in Recurr...
https://doi.org/10.1159/000510120
International Archives of Allergy and Immunology; Wu D, Yan B et. al.

Sep 14th, 2020 - The recurrence occurs frequently among patients with chronic rhinosinusitis with nasal polyps (CRSwNP), and predictors that could be conveniently detected during practice in outpatient service are needed. We aimed to illustrate that the concentrat...

Azithromycin for chronic eosinophilic rhinosinusitis with nasal polyp: a placebo-contro...
https://doi.org/10.4193/Rhin20.071
Rhinology de Oliveira IS, Guimaraes AF et. al.

Sep 14th, 2020 - Chronic eosinophilic rhinosinusitis with nasal polyps (CRSwNP eosinophilic) is characterised by the formation of benign and bilateral nasal polyps. We aimed to compare the effectiveness of azithromycin as an immunomodulator with the use of a place...

Denatonium benzoate bitter taste perception in chronic rhinosinusitis subgroups.
https://doi.org/10.1002/alr.22687
International Forum of Allergy & Rhinology References; Civantos AM, Maina IW et. al.

Sep 4th, 2020 - Chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) and CRS without nasal polyps (CRSsNP), and aspirin-exacerbated respiratory disease (AERD) have varying levels of inflammation and disease severity. Solitary chemosensory cells (SCCs) are enri...

Increased lipopolysaccharide content is positively correlated with glucocorticoid recep...
https://doi.org/10.1002/iid3.346
Immunity, Inflammation and Disease REFERENCES; Wang SB, Chen SM et. al.

Sep 1st, 2020 - Chronic rhinosinusitis with nasal polyps (CRSwNP) is a common and frequently occurring disease of the upper respiratory tract. The nasal instillation of the Gram-negative (G- ) bacterial product lipopolysaccharide (LPS) can induce not only acute s...

Systematic literature review of humanistic and economic burdens of chronic rhinosinusit...
https://doi.org/10.1080/03007995.2020.1815683
Current Medical Research and Opinion; Chen S, Zhou A et. al.

Aug 26th, 2020 - Objectives: We conducted a systematic literature review (SLR) of randomized controlled trials and real-world evidence (RWE) studies to determine the humanistic (e.g., health-related/disease-specific quality of life [QOL]) and economic (e.g., direc...

see more →

News  27 results

Dupilumab shrinks nasal polyps in severe chronic rhinosinusitus
https://www.mdedge.com/fedprac/article/210354/pulmonology/dupilumab-shrinks-nasal-polyps-severe-chronic-rhinosinusitus?channel=112
Ted Bosworth

Oct 17th, 2019 - MADRID – In adults with severe chronic rhinosinusitus with nasal polyps (CRSwNP), the monoclonal antibody dupilumab is effective for shrinking the polyps, improving symptoms, and reducing the need for systemic corticosteroids and surgery, accordin.

FDA approves Dupixent for chronic rhinosinusitis with nasal polyps
https://www.mdedge.com/pulmonary-health-hub/article/203634/pulmonology/fda-approves-dupixent-chronic-rhinosinusitis-nasal
Lucas Franki

Jun 26th, 2019 - The Food and Drug Administration has approved dupilumab (Dupixent) for the treatment of chronic rhinosinusitis accompanied by nasal polyps in adults. Wikimedia Commons/FitzColinGerald/Creative Commons License FDA approval is based on results from.

FDA approves dupilumab for chronic rhinosinusitis with nasal polyps
https://www.mdedge.com/familymedicine/article/203634/pulmonology/fda-approves-dupilumab-chronic-rhinosinusitis-nasal-polyps?channel=284
CHEST Physician; Lucas Franki

Jun 26th, 2019 - The Food and Drug Administration has approved dupilumab (Dupixent) for the treatment of chronic rhinosinusitis accompanied by nasal polyps in adults. FDA approval is based on results from a pair of studies involving 724 patients aged 18 years or o.

FDA approves expanded label for Regeneron/Sanofi's Dupixent
https://www.reuters.com/article/us-regeneron-pharms-fda-sanofi-fr/fda-approves-expanded-label-for-regeneron-sanofis-dupixent-idUSKCN1TR2RU

Jun 26th, 2019 - (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Regeneron Pharmaceuticals Inc and Sanofi SA’s drug Dupixent to treat nasal polyps, marking the third major use for the injectable medicine. FILE PHOTO: The Sanofi logo at the ...

Dupilumab to undergo FDA Priority Review for CRSwNP treatment
https://www.mdedge.com/familymedicine/article/195959/pulmonology/dupilumab-undergo-fda-priority-review-crswnp-treatment?channel=39313
CHEST Physician; Lucas Franki

Mar 8th, 2019 - The Food and Drug Administration will conduct a Priority Review on the supplemental Biologics License Application (sBLA) for dupilumab (Dupixent) as an add-on treatment for adults with inadequately controlled severe chronic rhinosinusitis with nas.

see more →

Patient Education  17 results see all →